Trial Profile

Evaluation of Safety and Efficacy of Zonisamide in Adult Patients with Partial, Generalized and Combined Seizures: An Open Labeled, Non-comparative, Observational Study Acronym: PMS Zonisamide

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 24 Aug 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Zonisamide (Primary)
Indications Generalised epilepsy; Partial epilepsies
Focus Therapeutic Use
Acronyms PMS Zonisamide
Sponsors Eisai Inc

Most Recent Events

26 Sep 2013 Interim results presented at the 21st World Congress of Neurology.
17 Jul 2013 Planned number of patients changed from 900 to 655 as reported by Clinical Trials Registry - India record.
14 Dec 2010 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com